↓ Skip to main content

Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals

Overview of attention for article published in Retrovirology: Research & Treatment, February 2013
Altmetric Badge

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
44 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals
Published in
Retrovirology: Research & Treatment, February 2013
DOI 10.1186/1742-4690-10-19
Pubmed ID
Authors

Yoshimi Enose-Akahata, Anna Abrams, Raya Massoud, Izabela Bialuk, Kory R Johnson, Patrick L Green, Elizabeth M Maloney, Steven Jacobson

Abstract

Human T cell lymphotropic virus type 1 (HTLV-1) infection can lead to development of adult T cell leukemia/lymphoma (ATL) or HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in a subset of infected subjects. HTLV-1 basic leucine zipper factor (HBZ) gene has a critical role in HTLV-1 infectivity and the development of ATL and HAM/TSP. However, little is known about the immune response against HBZ in HTLV-1-infected individuals. In this study, we examined antibody responses against HBZ in serum/plasma samples from 436 subjects including HTLV-1 seronegative donors, asymptomatic carriers (AC), ATL, and HAM/TSP patients using the luciferase immunoprecipitation system.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 2%
Brazil 1 2%
Unknown 42 95%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 23%
Researcher 9 20%
Student > Master 6 14%
Student > Ph. D. Student 5 11%
Student > Postgraduate 3 7%
Other 7 16%
Unknown 4 9%
Readers by discipline Count As %
Agricultural and Biological Sciences 20 45%
Medicine and Dentistry 7 16%
Immunology and Microbiology 5 11%
Biochemistry, Genetics and Molecular Biology 2 5%
Business, Management and Accounting 1 2%
Other 5 11%
Unknown 4 9%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2013.
All research outputs
#16,630,006
of 21,344,814 outputs
Outputs from Retrovirology: Research & Treatment
#136
of 215 outputs
Outputs of similar age
#207,551
of 281,897 outputs
Outputs of similar age from Retrovirology: Research & Treatment
#1
of 1 outputs
Altmetric has tracked 21,344,814 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 215 research outputs from this source. They receive a mean Attention Score of 2.6. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 281,897 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them